Shares of Merrimack Pharmaceuticals fell 5.14% to $7.20 at 15:19 EST on Tuesday, following last session’s upward trend. NASDAQ Composite is sliding 1.16% to $13,754.02, following last session’s downward trend, This seems, so far, an all-around rough trend trading session today.

Merrimack Pharmaceuticals’s last close was $7.59, 31.25% under its 52-week high of $9.45.

Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $7.20 at 15:19 EST, way under its 52-week high of $9.45 and way above its 52-week low of $2.97.

Merrimack Pharmaceuticals’s Moving Average

Merrimack Pharmaceuticals’s value is higher than its 50-day moving average of $6.88 and way above its 200-day moving average of $5.87.

More news about Merrimack Pharmaceuticals.


Please enter your comment!
Please enter your name here